Imricor Adds First Site in Greece

4 January 2022 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in realtime iCMR cardiac ablation products, is pleased to announce that the Henry Dunant Hospital Centre in Athens, Greece ( is the latest institution to adopt Imricor’s iCMR ablation solutions.

The Henry Dunant Hospital Centre, one of the largest and most technologically advanced hospital centers in Southeast Europe, making it the fourteenth Imricor site in Europe and is the first hospital in Greece to begin realtime iCMR ablations. The Company will outfit an existing MR facility for iCMR procedures, which are expected to begin in the first quarter of 2022 under the direction of electrophysiologist Professor George Andrikopoulos.

Imricor’s Chair and CEO, Steve Wedan, said: “We are very excited to work with Professor Andrikopoulos and his world-class team at Henry Dunant to bring iCMR cardiac ablations, for the first time, to patients in Greece.

“More broadly, we are very pleased to see the acceleration in our rate of site adoption, adding four sites in the last quarter of 2021, and we remain focused on growing our installed base across Europe, as we enter 2022 with great enthusiasm.” 

Expansion into Greece is a significant milestone for Imricor as it is a key strategic goal of Imricor to grow the number of sites performing realtime iCMR cardiac ablation procedures in Europe.

~ ~ ~ ~ ~
About Imricor